TABLE 1.
Knock-in CF animal models.
| Species | Mutation | Editing technology | Insertion | CF phenotype | References |
|---|---|---|---|---|---|
| Mouse | F508del | Plasmid | HR | Peritonitis, intestinal obstruction | Colledge et al. (1995) |
| Electrophysiological abnormalities in trachea and colon epithelium | |||||
| Distention and mucus hyper-accumulation in intestinal glands and colon mRNA expression lower than WT | |||||
| Mouse | F508del | Plasmid | HR | Growth retardation | van Doorninck et al. (1995) |
| Hypertrophy of goblet cells in intestine | |||||
| Residual CFTR function in nasal, intestinal and gallbladder epithelium | |||||
| Mouse | F508del | Plasmid | HR | Growth retardation | Zeiher et al. (1995) |
| Peritonitis, intestinal obstruction | |||||
| Electrophysiological abnormalities in nasal, intestinal and pancreatic epithelium | |||||
| Inflammatory cells in broncho-alveolar lavage | |||||
| Mouse | G551D | Plasmid | HR | Intestinal obstruction, peritonitis | Delaney et al. (1996) |
| Electrophysiological abnormalities in nasal, tracheal and intestinal epithelium | |||||
| Mouse | G480C | Plasmid | HR | Hypertrophy of goblet cells in intestine | Dickinson et al. (2002) |
| Electrophysiological abnormalities in nasal epithelium | |||||
| Mouse | R117H | NR | HR | Growth retardation | van Heeckeren et al. (2004) |
| Electrophysiological abnormalities in nasal epithelium | |||||
| Pig | F508del | rAAV | HR | Intestinal obstruction | Rogers et al. (2008), Ostedgaard et al. (2011) |
| Liver steatosis | |||||
| Pancreatic abnormalities | |||||
| CF lung disease: Airway obstruction, host-defense defect | |||||
| Residual CFTR function in nasal and pancreatic epithelium | |||||
| Mouse | G542X | CRISPR/Cas9 | HR | Growth retardation | McHugh et al. (2018) |
| Intestinal obstruction | |||||
| No CFTR activity in airway and intestinal epithelium | |||||
| Rat | F508del | CRISPR/Cas9 | HR | Growth retardation | Dreano et al. (2019) |
| Abnormal dentition | |||||
| Intestinal obstruction | |||||
| Residual CFTR function in airway and colon epithelium | |||||
| Ferret | G551D | rAAV | HR | Intestinal obstruction mRNA expression reduced in lung and intestine | Sun et al. (2019) |
| Protein expression reduced in lung | |||||
| Electrophysiological abnormalities in intestinal organoids, jejunum and pancreatic ductal epithelium | |||||
| Airway obstruction | |||||
| Reproductive tract malformations | |||||
| Rat | F508del | CRISPR/Cas9 | HR | Growth retardation | McCarron et al. (2020) |
| Abnormal dentition | |||||
| Intestinal obstruction | |||||
| Residual CFTR function in nasal epithelium | |||||
| Reproductive tract malformations | |||||
| Rat | G542X | CRISPR/Cas9 | HR | Growth retardation | Sharma et al. (2020) |
| Abnormal dentition | |||||
| Intestinal obstruction | |||||
| No CFTR activity in airway and intestinal epithelium mRNA degradation (NMD) |
Abbreviations: CRISPR/Cas, Clustered Regularly Interspaced Short Palindromic Repeats/CRISPR associated protein; HR, Homologous recombination based on the presence of flanking homology arms; KO, Knock-out; NMD, Nonsense-mediated decay; NPD, Nasal potential difference; WT, Wild-type.